EPIGENESIS.BIZ
DEAD

Serial Number

76320650

Owner

EPIGENESIS Pharmaceuticals, Inc.

Attorney

VIVIANA AMZEL

Filing Date

Oct 3, 2001

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENESIS.BIZ Trademark

Serial Number: 76320650

EPIGENESIS.BIZ is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on October 3, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Trademark Details

Filing Date

October 3, 2001

Registration Date

Not Registered

Published for Opposition

October 22, 2002

Goods & Services

Medical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments , including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, , impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g. cancers which metastasized to the lung(s), breast, liver and prostate

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Sep 26, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2003 NOAM
PUBLISHED FOR OPPOSITION
Oct 22, 2002 PUBO
NOTICE OF PUBLICATION
Oct 2, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2002 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 5, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2002 CRFA
NON-FINAL ACTION MAILED
Dec 13, 2001 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2001 DOCK
ASSIGNED TO EXAMINER
Dec 10, 2001 DOCK
ASSIGNED TO EXAMINER
Dec 10, 2001 DOCK